Entellus Medical (ENTL) Tops Q2 EPS by 8c; Guides FY16 Revenue

Entellus Medical (NASDAQ: ENTL) reported Q2 EPS of ($0.27), $0.08 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $18.7 million versus the consensus estimate of $18.48 million.

GUIDANCE:

Entellus Medical sees FY2016 revenue of $74-77 million, versus the consensus of $75.9 million.

For earnings history and earnings-related data on Entellus Medical (ENTL) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
• Oxford Industries (OXM) Tops Q2 EPS by 4c; offers guidance
• lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance